Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "The Story"

My point as well, the 10Q should be "the event" that ignites our PR campaine. I'm thinking RG is going to make it happen for us. It's in his best interest, ours and PTSC's to attract new investors. You would think this would be a top priority after the 10Q is released.

All the best,

Steve

Share
New Message
Please login to post a reply